Intrexon Profile

16.15
USD 0.31  1.88%
40%
45%

Intrexon exotic insider transaction detected

Intrexon Corporation insider trading alert for general transaction of common stock by Randal Kirk, Chief Executive Officer, on June 17, 2018. This event was filed by Intrexon Corp with SEC on 2016-08-02. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Intrexon Summary

Intrexon Corporation (XON) is traded on New York Stock Exchange in USA. It is located in VIRGINIA, U.S.A and employs 906 people. Intrexon is listed under Business Services category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with total capitalization of 2.13 B. Intrexon Corporation runs under Healthcare sector within Business Services industry. This company has 129.29 M outstanding shares of which 23.36 M shares are at this time shorted by investors with about 19.94 days to cover shorted positions. Intrexon Corporat has about 123.5 M in cash with (109.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.95.
Check Intrexon Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 16.15HorizonTargetOdds Above 16.15
38.52%30 days 16.15 61.19%
Based on normal probability distribution, the odds of Intrexon to move above current price in 30 days from now is about 61.19% (This Intrexon Corporation probability density function shows the probability of Intrexon Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Third Security LlcCommon Shares59.1 M906.5 M
Iridian Asset Management LlcCommon Shares6.5 M100.1 M
Lmm LlcCall Options1000 K15.3 M
Susquehanna International Group LlpPut Options537.6 K8.2 M
View Intrexon Diagnostics

Selected Intrexon Corporation Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Intrexon Against Markets

Risk Adjusted
Performance Score (0 to 100)
11 
Chance of
Financial Distress (0 to 100%)
43 
Equity ratings for Intrexon Corporation are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Intrexon Corporation operates in the synthetic biology field in the United States. Intrexon Corporation was founded in 1998 and is based in Germantown, Maryland. Intrexon operates under Biotechnology classification in USA and traded on New York Stock Exchange. It employs 906 people. more
Fama & French Business Services
Business Services
Fama & French Classification
NameIntrexon Corporation
Chairman of the Board, CEORandal KirkView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock View All
RegionNorth America
LocationVIRGINIA, U.S.A
Business Address20374 Seneca Meadows Parkway
ExchangeNew York Stock Exchange
CIK Number01356090.0
CUSIP46122T102
SectorHealthcare
IndustryBusiness Services
BenchmarkDOW
Websitewww.dna.com
Contact Number301 556 9900
CurrencyUSD - US Dollar

Recommendations

Intrexon Analyst Recommendations
Target PriceAdvice# of Analysts
44.14Buy7Odds
Intrexon Corporation current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Intrexon Analyst Advice  

Earnings

Intrexon Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.23March 1, 2017
Intrexon Corporation normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Directors

Intrexon Corporate Directors
Steven Frank Independent Director, MBA
Cesar Alvarez Independent Director
Dean Mitchell Independent Director
See also Your Current Watchlist. Please also try Headlines Timeline module to stay connected to all market stories and filter out noise. drill down to analyze hype elasticity.